Statement Of Cash Flows [Abstract]

Imerys - Filing #5984053

Concept 2024-01-01 to
2024-12-31
2023-01-01 to
2023-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Increase (decrease) in working capital
200,000,000 EUR
1,007,000,000 EUR
Adjustments for depreciation and amortisation expense and impairment loss (reversal of impairment loss) recognised in profit or loss
3,015,000,000 EUR
5,106,000,000 EUR
Adjustments for undistributed profits of investments accounted for using equity method
1,095,000,000 EUR
906,000,000 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.